This company has been marked as potentially delisted and may not be actively trading. Aesther Healthcare Acquisition (AEHA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AEHA vs. TRVN, VINC, OBSV, SYRS, ARDS, SCPS, VRPX, EVLO, CMRA, and STABShould you be buying Aesther Healthcare Acquisition stock or one of its competitors? The main competitors of Aesther Healthcare Acquisition include Trevena (TRVN), Vincerx Pharma (VINC), ObsEva (OBSV), Syros Pharmaceuticals (SYRS), Aridis Pharmaceuticals (ARDS), Scopus BioPharma (SCPS), Virpax Pharmaceuticals (VRPX), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), and Statera Biopharma (STAB). These companies are all part of the "pharmaceutical preparations" industry. Aesther Healthcare Acquisition vs. Its Competitors Trevena Vincerx Pharma ObsEva Syros Pharmaceuticals Aridis Pharmaceuticals Scopus BioPharma Virpax Pharmaceuticals Evelo Biosciences Comera Life Sciences Statera Biopharma Trevena (NASDAQ:TRVN) and Aesther Healthcare Acquisition (NASDAQ:AEHA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Is TRVN or AEHA more profitable? Company Net Margins Return on Equity Return on Assets TrevenaN/A N/A -119.55% Aesther Healthcare Acquisition N/A N/A N/A Do institutionals and insiders believe in TRVN or AEHA? 13.6% of Trevena shares are owned by institutional investors. Comparatively, 78.6% of Aesther Healthcare Acquisition shares are owned by institutional investors. 2.7% of Trevena shares are owned by company insiders. Comparatively, 19.8% of Aesther Healthcare Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, TRVN or AEHA? Trevena has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500. Comparatively, Aesther Healthcare Acquisition has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Which has higher earnings and valuation, TRVN or AEHA? Aesther Healthcare Acquisition has lower revenue, but higher earnings than Trevena. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrevena$443K0.54-$40.29M-$47.04-0.01Aesther Healthcare AcquisitionN/AN/A-$560KN/AN/A Does the media favor TRVN or AEHA? In the previous week, Trevena's average media sentiment score of 0.00 equaled Aesther Healthcare Acquisition'saverage media sentiment score. Company Overall Sentiment Trevena Neutral Aesther Healthcare Acquisition Neutral Do analysts rate TRVN or AEHA? Trevena presently has a consensus target price of $5.00, indicating a potential upside of 1,900.00%. Given Trevena's stronger consensus rating and higher probable upside, analysts plainly believe Trevena is more favorable than Aesther Healthcare Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aesther Healthcare Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTrevena and Aesther Healthcare Acquisition tied by winning 4 of the 8 factors compared between the two stocks. Get Aesther Healthcare Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for AEHA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEHA vs. The Competition Export to ExcelMetricAesther Healthcare AcquisitionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$85K$736.37M$5.84B$10.14BDividend YieldN/A4.84%5.68%4.60%P/E RatioN/A1.1775.4125.98Price / SalesN/A26.64515.81181.13Price / CashN/A19.5637.5660.44Price / Book-0.056.6812.156.29Net Income-$560K-$4.13M$3.29B$271.07M Aesther Healthcare Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEHAAesther Healthcare AcquisitionN/A$0.01+1.6%N/A-99.9%$85KN/A0.002,021Gap DownHigh Trading VolumeTRVNTrevena1.6841 of 5 stars$0.25+20,733.3%$5.00+1,900.0%-95.8%$240K$443K-0.0140Gap UpVINCVincerx Pharma3.2917 of 5 stars$0.03+3.5%$40.00+122,976.9%-99.7%$170KN/A0.0060Short Interest ↓OBSVObsEvaN/AN/AN/AN/A$39KN/A0.0050SYRSSyros Pharmaceuticals4.2738 of 5 stars$0.00-35.3%$1.00+90,809.1%-99.9%$30K$386K0.00120Short Interest ↓Gap DownARDSAridis PharmaceuticalsN/A$0.00+400.0%N/AN/A$27KN/A0.0030Gap DownSCPSScopus BioPharmaN/A$0.00flatN/AN/A$17KN/A0.009Gap DownVRPXVirpax Pharmaceuticals0.1833 of 5 stars$0.01+2.5%N/AN/A$15KN/A0.007Gap DownEVLOEvelo BiosciencesN/A$0.00flatN/A-97.8%$9KN/A0.00120CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002STABStatera BiopharmaN/A$0.00-50.0%N/A+0.0%$5KN/A0.0020Gap Down Related Companies and Tools Related Companies TRVN Alternatives VINC Alternatives OBSV Alternatives SYRS Alternatives ARDS Alternatives SCPS Alternatives VRPX Alternatives EVLO Alternatives CMRA Alternatives STAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEHA) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aesther Healthcare Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aesther Healthcare Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AEHA Stock Alerts